Prognosis
Sanofi to Make Millions of BioNTech-Pfizer Vaccine Doses
- Collaboration will help boost European Union’s vaccine supply
- Companies pledge more than 125 million doses of mRNA shot
This article is for subscribers only.
Sanofi agreed to produce millions of doses of BioNTech SE and Pfizer Inc.’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts.
The French drugmaker will give BioNTech access to a production facility in Frankfurt, which will start to deliver doses this summer, Sanofi said in a statement Wednesday. The deal will produce more than 125 million doses of the messenger RNA vaccine for the European Union.